Thomas Heiberg Brix

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 893 citations · Full text

Translational Medicine, Parathyroid Hormone, Pharmacology +14

Evidence for a Major Role of Heredity in Graves’ Disease: A Population-Based Study of Two Danish Twin Cohorts¹

Thomas Heiberg Brix, Kirsten Ohm Kyvik, Kaare Christensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 408 citations · Full text

Major Genetic Influence on the Regulation of the Pituitary-Thyroid Axis: A Study of Healthy Danish Twins

Pia Skov Hansen, Thomas Heiberg Brix, Thorkild I. A. Sørensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 260 citations · Full text

Genetics, Genetic Epidemiology, Epigenetics +22

The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors.

Birgitte Rasmussen, Thomas Heiberg Brix, Kirsten Ohm Kyvik et al. · Pharmacogenetics · 2002 · 235 citations

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

George J. Kahaly, Michaela Riedl, J. König et al. · The Lancet Diabetes & Endocrinology · 2018 · 212 citations

Methylprednisolone Versus Methylprednisolone, Endocrine Disease, Medicine +5